- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07575594
The Use of White Noise and Quiet Time During Labor (White & Quiet)
The Effect of White Noise and Quiet Time Interventions During Labor on Labor Pain, Stress, and Satisfaction
Childbirth is defined as the process in which the fetus and its appendages are expelled from the uterus. The World Health Organization emphasizes that women should have a positive childbirth experience and recommends interventions that reduce pain and stress while increasing maternal satisfaction.
White noise, defined as continuous and monotonous sounds such as wave, water, or wind sounds, and quiet time, described as periods in which environmental noise is minimized, have been shown to reduce pain and stress and improve satisfaction in various patient groups. However, there is a lack of evidence regarding their effects during labor.
Therefore, this study was planned to evaluate the effects of white noise and quiet time interventions applied during labor on perceived labor pain, stress levels, and childbirth satisfaction.
Visão geral do estudo
Status
Intervenção / Tratamento
Descrição detalhada
Childbirth is defined as a process in which the fetus and its appendages are expelled from the uterus. The World Health Organization emphasizes that women should have a positive childbirth experience. During childbirth, care providers are recommended to implement interventions that reduce women's pain and stress and increase satisfaction.
White noise is defined as continuous and monotonous sounds such as wave, water, and wind sounds. It has been studied in postoperative patients, infants, and neonates.
Quiet time is defined as a period in which environmental sounds are minimized. It has been studied in postpartum women, patients in acute care units, nurses working in neonatal intensive care units, and infants.
White noise and quiet time interventions have been found to be methods used to reduce pain and stress and to increase satisfaction. However, no study has been found that evaluates the effects of white noise and quiet time interventions on pain, stress, and satisfaction during the childbirth process. Therefore, this study was planned to evaluate the effects of white noise and quiet time interventions applied during childbirth on the level of perceived labor pain, stress level, and childbirth satisfaction.
Tipo de estudo
Inscrição (Real)
Contactos e Locais
Locais de estudo
-
-
-
Istanbul, Turquia (Türkiye)
- Esenler Women's and Children's Diseases Hospital
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
Aceita Voluntários Saudáveis
Método de amostragem
População do estudo
Descrição
Inclusion Criteria:
Pregnant women aged 18-35 years Pregnant women without a diagnosis of high-risk pregnancy Pregnant women with a gestational age between 37-42 weeks Pregnant women who will have a vaginal delivery Pregnant women in the active phase of labor Pregnant women who can speak or understand Turkish Pregnant women carrying a singleton fetus Primiparous women
Exclusion Criteria:
Pregnant women in the latent phase of labor Pregnant women with hearing impairment Pregnant women who are illiterate Pregnant women with an indication for cesarean section Multiparous women
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
Coortes e Intervenções
Grupo / Coorte |
Intervenção / Tratamento |
|---|---|
|
White Noise Group
Participants received white noise via Bluetooth headphones during active labor at 6 cm and 8 cm cervical dilation (15 minutes each, 50-65 dB).
Pain and stress were assessed using VAS, and maternal satisfaction was evaluated postpartum.
|
Participants received white noise intervention during the active phase of labor. At 4 cm cervical dilation, informed consent was obtained and baseline assessments including Demographic Information Form, Visual Analogue Scale (VAS) for pain, and Visual Analogue Scale for stress were completed. Routine care was provided. At 6 cm and 8 cm cervical dilation, participants were exposed to white noise (50-65 dB) via Bluetooth headphones for 15 minutes each session. Routine monitoring and standard obstetric care were continued. After interventions, pain and stress were reassessed using VAS. At the second postpartum hour, maternal satisfaction was assessed using the Maternal Satisfaction in Childbirth Scale. |
|
Quiet Time Group
At the beginning of the active phase (when cervical dilation was 4 cm), the participant was informed about the study and informed consent was obtained. The Demographic Information Form was completed, and pain was assessed using the Visual Analogue Scale (VAS), while stress was evaluated using a Visual Analogue Scale (VAS). Routine monitoring and standard care were provided. At 6 cm cervical dilation during the active phase, quiet time was provided for 15 minutes using Polter headphones. Routine monitoring and standard care were continued. At 8 cm cervical dilation during the active phase, quiet time was again provided for 15 minutes using Polter headphones. Routine monitoring and standard care were continued. After the intervention, pain was assessed using the Visual Analogue Scale (VAS), and stress was evaluated using a Visual Analogue Scale (VAS). At the second hour postpartum, the Maternal Satisfaction in Childbirth Scale was completed. |
Participants received quiet time intervention during the active phase of labor. At 4 cm cervical dilation, informed consent was obtained and baseline assessments including Demographic Information Form, Visual Analogue Scale (VAS) for pain, and Visual Analogue Scale for stress were completed. Routine care was provided. At 6 cm and 8 cm cervical dilation, a quiet environment was maintained using Polter headphones for 15 minutes per session. Routine monitoring and standard obstetric care were continued. After interventions, pain and stress were reassessed using VAS. At the second postpartum hour, maternal satisfaction was assessed using the Maternal Satisfaction in Childbirth Scale. |
|
Control Group
At the beginning of the active phase (when cervical dilation was 4 cm), the participant was informed about the study and informed consent was obtained. The Demographic Information Form was completed, and pain was assessed using the Visual Analogue Scale (VAS), while stress was evaluated using a Visual Analogue Scale (VAS). Routine monitoring and standard care were provided. The participant received routine care throughout the active phase. At the end of the phase, pain was assessed using the Visual Analogue Scale (VAS), and stress was evaluated using a Visual Analogue Scale (VAS). Routine care was continued. At the second hour postpartum, the Maternal Satisfaction in Childbirth Scale was completed. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Pain level during labor
Prazo: During labor, between 4-10 cm cervical dilation (latent and active phases)
|
Labor pain levels will be assessed using the Visual Analog Scale (VAS).
Measurements will be performed during the latent and active phases of labor at specific cervical dilation stages (4-10 cm).
|
During labor, between 4-10 cm cervical dilation (latent and active phases)
|
Colaboradores e Investigadores
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 2025/55
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .